2Rose MA,Kam PCA.Gabapentin:pharmacology and its use in pain management.Anaesthesia,2002,57:451 ～ 462.
3Armijo JA,Pena MA,Adin J,et al.Association between patient age and gabapentin serum concentration-to-dose ratio:a preliminary multivariate analysis.Ther Drug Monit,2004,26:633 ～637.
4Richens A.Clinical pharmacokinetics of gabapentin.In:New Trends in Epilepsy Management:The Role of Gabapendin.Royal Sociaty of Medicine,1993,41 ～46.
5Busch JA,Radulovic LL,Bockbrader HN,et al.Effect of Maalox TC on single-dose pharmocokinetics of gabapentin capsules in healthy subjects.Pharmaceutical Reserch,1992,9 (Suppl) :S ～315.
6Taylor CP,Vartanian MG,Yuen P,et al.Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labelled by tritiated gabapentin.Epilepsy reserch,1993,14:11 ～ 15.
7Pan HL,Eisenach JC,Chen SR.Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats.Journal of Pharmacology and Experimental Therapeutics,1999,288 :1026～ 1030.
8Bennett MI,Simpson KH.Gabapentin in the treatment of neuropathic pain.Palliat Med,2004,18:5～11.
9Yoon MH,Yaksh TL.The effect of intrathecal gabapentin on pain behaviour and hemodynamics on the formalin test in the rat.Anesthesia and Analgesia,1999,89:434～439.
10Dooley DJ,Mieske CA,Borosky SA.Inhibition of K (+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin.Neuroscience Letters,2000,280:107 ～ 110.
